International Society for the Study of Women's Sexual Health

Role of Biotechnology and Pharmaceutical Companies in Developing Novel Therapies for Female Sexual Dysfunction

Female sexual disorders have historically been treated with multiple non-medical and off-label medical therapies by a limited number of experienced clinicians. Yet, most therapies have insufficient clinical evidence to support their safety and efficacy. Thus, the development of safe and effective therapies for the treatment of sexual disorders in women is critical to improving the overall management of these conditions, and increasing access to care. The International Society for the Study of Women’s Sexual Health (ISSWSH) supports the role of biotechnology and pharmaceutical companies, and other investigators developing novel therapies for female sexual dysfunction. ISSWSH rejects a “one size fits all” approach to treating female sexual dysfunction due to the multiplicity of biopsychosocial factors that impact sexual health. The concept of personalized medicine, and the availability of multiple therapeutic options are critical in this field.
Category: Resources

Slide Deck Order Form

Order today! A 304 slide resource on Female Sexual Function and Dysfunction, plus over 50 reference slides!

Please see below the table of contents.

Fill out your name and email (IMPORTANT! We will use this email to send you the slides) and click on the "Buy Now" button.

Pricing

Non-members: USD 100.00
Members:
USD 30.00 (log in to get the discounted price)
After login you find the Slide Deck order form under Members Only in the navigation bar.

Non-Member order form
Your name
Your email
Slide Deck Table of Contents
  • Epidemiology and Definitions (3-19)
  • Anatomy and Pathology (20-31)
  • Sexual History Taking (32-47)
  • Female Sexual Dysfunction (48-141)
    • Hypoactive Sexual Desire Disorder (48-62)
    • Female Genital Arousal Disorder (63-66)
    • Persistent Genital Arousal Disorder (67-77)
    • Orgasm Disorders (78-89)
    • Sexual Pain Disorders (90-112)
      • Vulvar Skin Disorder (113-141)
  • Female Sexual Dysfuntion in Special Circumstances (142-166)
    • Aging/Menopause/GSM (142-166)
      • Menopausal Hormone Therapy (167-185)
    • Androgen Deficiency (186-195)
    • Infertility (196-201)
    • Pregnancy and Postpartum (202-218)
    • Gynecologic Cancer (219-230)
    • Benign Gynecologic Conditions (231-242)
    • Psychiatric Disorders (243-257)
    • Obesity (258-259)
  • Treatments for Female Sexual Dysfunction (260-304)
    • Lubricants, Moisturizers, Vibrators (260-271)
    • Sex Therapy Approaches (272-282)
    • Current and Future Pharmacotherapies (283-304)
  • References (305-357)
Category: Resources

Clinical Pearls

ISSWSH membership comes with several benefits, one of which is access to Clinical Pearls. Written and reviewed by the Practice Pearls Committee, clinical pearls provide small bits of free standing, clinically relevant information based on experience or observation.1 These Clinical Pearls can provide guidance to practitioners dealing with clinical issues for which controlled data do not exit.

1Lorin MI, Palazai DL, Ward MA. What is a clinical pearl and what is its role in medical education? Med Teach. 2008;30(9-10):870-874.


You will find the Clinical Pearls under "Your ISSWSH Resources".

 

Not a Member Yet? Apply for ISSWSH Membership Today!
Category: Resources

Subcategories

  • Books

    If you have a book you would like listed below, please contact the ISSWSH office at (218) 461-5115 or email This email address is being protected from spambots. You need JavaScript enabled to view it..

    The following information is posted by ISSWSH members and is not necessarily endorsed by the ISSWSH. 


  • JSM
  • Bulletin Board
  • Publications

Latest Tweets

Epidemiologic Study of #FemaleSexualDysfunction Risk in Mainland China: Prevalence and Predictors. Study finds… https://t.co/5xElDHMX23 ISSWSH
Women report that having clitoris stimulated during intercourse increases the likelihood of experiencing orgasm… https://t.co/NVtwahixDH ISSWSH
RT @SexHlthMatters: An estimated 33 million Americans suffer from overactive bladder. This study investigated how #OAB can affect women’s s… ISSWSH